Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain
Jesús Troya, Paul Bastard, Laura Planas‐Serra, Pablo Ryan, Montserrat Ruíz, María de Carranza, Juan Torres‐Macho, Amalia Martínez, Laurent Abel, Jean‐Laurent Casanova, Aurora Pujol
Topics & Concepts
AutoantibodyMedicinePneumoniaImmunologyCohortAsymptomaticInternal medicineAntibodyCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchImmune responses and vaccinations